This is a mix-shift thesis, not a raw demand thesis. The company already has access to real defense and security budgets, so the upside comes from proving that secure
GenAI, regulated screening, and auditable workflow control can scale faster than services. If that happens, revenue can compound well above normal contractors, but the starting valuation and
dilution capacity likely cap the
rerating. That supports a good, not extreme, 5-year outcome.